Nektar TherapeuticsNKTRNASDAQ
Loading
Total debt minus cash and cash equivalents
3Y CAGR
+45.7%/yr
vs -4.5%/yr prior
Acceleration
+50.2pp
Accelerating
Percentile
P64
Within normal range
vs 3Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $133.79M | +129.4% |
| 2024 | $58.31M | -29.3% |
| 2023 | $82.50M | +90.7% |
| 2022 | $43.27M | -63.3% |
| 2021 | $117.96M | +342.4% |
| 2020 | $-48.67M | -115.6% |
| 2019 | $311.77M | +499.0% |
| 2018 | $52.05M | -78.4% |
| 2017 | $240.44M | +27.2% |
| 2016 | $188.96M | - |